Techh.info/biomedtechnology hourly

Headlines

headlines texts
19.01.2019
04:49 ScienceDaily.comScientists learn how common virus reactivates after transplantation

A new study challenges long-held theories of why a common virus -- cytomegalovirus, or CMV -- can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer patients undergoing bone marrow transplantation.

Скрыть анонс
00:47 MedicalNewsToday.comMedical News Today: Our guide to the Mediterranean diet

The Mediterranean diet focuses on whole foods and includes plenty of fruits and vegetables. Learn about the benefits and see a sample meal plan here.

Скрыть анонс
18.01.2019
23:11 Gizmag Lab-grown human blood vessels promise breakthroughs in the fight against diabetes


Stem cell researchers at the University of British Columbia (UBC) have successfully managed to grow human blood vessels in the lab. The finding could mark a giant leap forward in the fight against vascular diseases such as Alzheimer's, cancer, and diabetes by allowing risk-free experimentation on live human tissue.
.. Continue Reading Lab-grown human blood vessels promise breakthroughs in the fight against diabetes Category: Science Tags: blood vessel Diabetes Stem Cells University of British Columbia

Скрыть анонс
21:44 WhatReallyHappened.comMONSANTO/BAYER MOVING TO GENOME EDIT FRUITS AND MORE

Not surprising, Monsanto, today hidden behind the Bayer logo, as the world leader in patented GMO seeds and the probable carcinogenic Roundup herbicide with glyphosate, is attempting to quietly patent genetically modified or GMO varieties of fruits using controversial gene-editing. The “beauty” of this for Monsanto/Bayer is that in the USA, according to a recent ruling by the US Department of Agriculture, gene-edited agriculture needs no special independent testing. The developments are not good for human health or safety, nor will it do anything to give the world better nutrition.
The agrichemical and GMO giant Monsanto, which today tries to keep a lower profile inside the German agrichemical and GMO giant Bayer, is moving into the highly controversial domain of gene-editing of new crop varieties. In 2018 as the company was being deluged with lawsuits over its use of the probable

Скрыть анонс
20:50 WhatReallyHappened.com'Longevity' Could Reach Billions In 2019 - And Is No Longer Just The Preserve of Billionaires

At-home DNA testing kits were one of the most fashionable Christmas gifts this year. And with companies like AncestryDNA, MyHeritage, and 23andMe offering kits for as little as £75 - less than the cost of the latest Amazon Echo – it is no wonder they appeal to those with the curiosity to know the most intimate information on themselves and their families.
While DNA testing has reached the mainstream, it is only 15 years since the official completion of the Human Genome Project and the publication of the first genome sequence at a cost of over $3 billion.
But DNA analysis has far more implications for humanity than understanding our genealogical roots or risk of disease. The vast global DNA library resulting from mass genomic profiling is helping us understand how we could extend “longevity”, that is living younger and healthier for longer. It also means the search for the elixir of

Скрыть анонс
19:44 Phys.orgNanoparticle breakthrough in the fight against cancer

A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer.

Скрыть анонс
17:28 ScienceDaily.comGene therapy promotes nerve regeneration

Researchers have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated. The discovery is an important step towards the development of a new treatment for people with nerve damage.

Скрыть анонс
14:24 Technology.orgPoo transplant effective treatment for chronic Bowel condition

Poo transplant or “Faecal microbiota transplantation” (FMT) can successfully treat patients with ulcerative colitis, new research from the

Скрыть анонс
14:12 TechnologyReview.comWe won’t use CRISPR to make super-smart babies—but only because we can’t

Gene experts speculate that our worst gene-editing fears won’t come true because they are too complex for us to pull them off.

Скрыть анонс
14:11 NYT HealthAsk Well: What Is a Fecal Transplant, and Why Would I Want One?

Fecal transplant is used to treat gut infections and is now being studied as a treatment for obesity, urinary tract infections, irritable bowel syndrome and more.

Скрыть анонс
12:44 MedicalNewsToday.comMedical News Today: Stem cell transplant slows down MS progression

Clinical trial compares stem cell transplantation with existing disease-modifying therapies and finds that the former is more effective at slowing down MS.

Скрыть анонс
11:06 News-Medical.NetScientists develop new gene therapy that prevents axon destruction in mice

Nerve axons serve as the wiring of the nervous system, sending electrical signals that control movement and sense of touch.

Скрыть анонс
09:39 Gizmag Turning stem cells into insulin-producing cells could lead to "functional" diabetes cure


While diabetes can mostly be managed through a carefully-controlled diet and regular insulin shots, a longer term solution and perhaps even a cure could be found by replenishing a patient's own supply of beta cells, which naturally produce the hormone. Researchers at Washington University in St. Louis are a step closer to that kind of treatment, after tweaking the recipe for turning stem cells into beta cells.
.. Continue Reading Turning stem cells into insulin-producing cells could lead to "functional" diabetes cure Category: Biology Tags: Diabetes Hormone Induced Pluripotent Stem Cells (iPS) Insulin Stem Cells Washington University in St Louis Washington University in St. Louis

Скрыть анонс
05:39 ScienceDaily.comNew hope for stem cell approach to treating diabetes

Researchers have tweaked the recipe for coaxing human stem cells into insulin-secreting beta cells and shown that the resulting cells are more responsive to fluctuating glucose levels in the blood.

Скрыть анонс
04:11 ScienceDaily.comGene therapy blocks peripheral nerve damage in mice

Scientists have developed a gene therapy that blocks axonal degeneration, preventing axon destruction in mice and suggesting a therapeutic strategy that could help prevent the loss of peripheral nerves in multiple conditions.

Скрыть анонс
00:38 TechInvestorNews.comFormer Google exec Vic Gundotra has stepped down as CEO of AliveCor, a health-tracking start-up (CNBC: Top News)

CNBC: Top NewsFormer Google exec Vic Gundotra has stepped down as CEO of AliveCor, a health-tracking start-up - AliveCor is best known for its Apple Watch band that includes a tiny electocardiogram sensor. It now competes with Apple, but Gundotra said the company just had its best quarter ever and that he stepped down for personal reasons. ...

Скрыть анонс
17.01.2019
22:47 CNBC health careFormer Google exec Vic Gundotra has stepped down as CEO of AliveCor, a health-tracking start-up

AliveCor is best known for its Apple Watch band that includes a tiny electocardiogram sensor. It now competes with Apple, but Gundotra said the company just had its "best quarter ever" and that he stepped down for personal reasons.

Скрыть анонс
21:41 CNBC technologyFormer Google exec Vic Gundotra has stepped down as CEO of AliveCor, a health-tracking start-up

AliveCor is best known for its Apple Watch band that includes a tiny electocardiogram sensor. It now competes with Apple, but Gundotra said the company just had its "best quarter ever" and that he stepped down for personal reasons.

Скрыть анонс
21:41 CNBC top newsFormer Google exec Vic Gundotra has stepped down as CEO of AliveCor, a health-tracking start-up

AliveCor is best known for its Apple Watch band that includes a tiny electocardiogram sensor. It now competes with Apple, but Gundotra said the company just had its "best quarter ever" and that he stepped down for personal reasons.

Скрыть анонс
19:34 NewScientist.ComAI chemist figures out how to legally clone expensive patented drugs

Pharma firms protect their drugs with hundreds of complex patents but an AI called Chematica can find workarounds, which could potentially make drugs cheaper

Скрыть анонс
19:05 Nanowerk.comNanoparticle breakthrough in the fight against cancer

Scientists have introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.

Скрыть анонс
19:04 News-Medical.NetStem cell-based approach to diabetes offers hope for treatment

Researchers developed a new stem-cell based approach to treating diabetes that improves how recipients respond to fluctuating glucose levels in the blood.

Скрыть анонс
19:01 ScienceDaily.comNanoparticle breakthrough in the fight against cancer

A recent study has introduced a novel targeted drug delivery system in the fight against cancer.

Скрыть анонс
13:35 TechInvestorNews.comIn search of the fountain of youth, beauty companies turn to tech (Jenny McGrath/Digital Trends)

Jenny McGrath / Digital TrendsIn search of the fountain of youth, beauty companies turn to tech - Beauty tech is a fairly new concept, but at CES 2019, companies such as Olay, LOreal, and Neutrogena were fully embracing it with all kinds of gadgets that promise to give you glowing skin. The post In search of the fountain of youth, beauty companies turn to tech appeared first ...

Скрыть анонс
12:49 AzoRobotics.comRobocath’s R-One™ Robot Acquired by the Medical Training and Testing Center in Rouen for Future Healthcare Practitioner Training

Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that the Medical Training & Testing Center...

Скрыть анонс
11:42 Technology.orgPoop transplant can effectively help people with ulcerative colitis

Here‘s something you haven‘t thought about today – poop transplant. Although it sounds like a bad example of

Скрыть анонс
06:38 Gizmag New fecal transplant technique successfully treats inflammatory bowel disease


While several decades of research have slowly been building a scientific case for the efficacy of fecal transplants as a treatment for a variety of conditions, there is still a lack of consensus over the best way to prepare and administer these fecal samples. A new Australian trial has revealed significant success in fecal transplants treating ulcerative colitis, pioneering a new stool processing technique suggested to enhance the therapeutic effect of the treatment.
.. Continue Reading New fecal transplant technique successfully treats inflammatory bowel disease Category: Medical Tags: Bacteria Disease fecal transplant Gut Bacteria Inflammatory Microbiome

Скрыть анонс
16.01.2019
23:20 FierceBiotech.comNIH’s stem cell-based AMD therapy set for first human trial

Researchers at the NIH’s National Eye Institute (NEI) have developed a therapy from induced pluripotent stem cells to prevent blindness in dry age-related macular degeneration, and they have turned up positive animal data that set the stage for a human trial.

Скрыть анонс
22:08 ScienceDaily.comHow stem cells self-organize in the developing embryo

New study uses live imaging to understand a critical step in early embryonic development -- how genes and molecules control forces to orchestrate the emergence of form in the developing embryo. The study findings could have important implications for how stem cells are used to create functional organs in the lab, and lead to a better understanding of the underlying causes of gastrointestinal birth defects.

Скрыть анонс
21:05 Phys.orgHow stem cells self-organize in the developing embryo

Embryonic development is a process of profound physical transformation, one that has challenged researchers for centuries. How do genes and molecules control forces and tissue stiffness to orchestrate the emergence of form in the developing embryo? How are the precise mechanics underlying emergence of the complexity of our organs and tissues encoded in our DNA?

Скрыть анонс
17:18 FierceBiotech.comLife Biosciences raises $50M as longevity race heats up

Life Biosciences has raised $50 million. The series B round will support the startup’s efforts to build a portfolio of subsidiaries with assets targeting eight aging pathways.

Скрыть анонс
15:05 ScientificAmerican.ComHuman Gene Editing: Great Power, Great Responsibility

Modifying the human germline has profound implications and must be approached with extraordinary care -- Read more on ScientificAmerican.com

Скрыть анонс
13:50 Technology.orgClinical Trial Testing Fecal Microbiota Transplant for Recurrent Diarrheal Disease Begins

A research consortium recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by

Скрыть анонс
12:18 Nature.ComThe paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief

Скрыть анонс
10:16 News-Medical.NetPoo transplant can successfully treat patients with ulcerative colitis

Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.

Скрыть анонс
09:54 News-Medical.NetResearchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases

For the first time, researchers at the George Washington University, together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer.

Скрыть анонс
08:14 News-Medical.NetMultiple sclerosis could benefit from stem cell therapy

Patients with relapsing multiple sclerosis (MS) have benefited from an experimental stem cell therapy. MS is an autoimmune disease where the central nervous system is affected. It is severely debilitating and means a slow and progressive death for the patients.

Скрыть анонс
08:04 News-Medical.NetStudy analyzes vaccine-preventable infections in children who receive solid organ transplants

Children who receive solid organ transplants are hospitalized due to vaccine-preventable infections at rates that are significantly higher than the general population, according to a newly published study by University of Colorado School of Medicine researchers.

Скрыть анонс
06:29 Arxiv.org CSSISC: End-to-end Interpretable Discovery Radiomics-Driven Lung Cancer Prediction via Stacked Interpretable Sequencing Cells. (arXiv:1901.04641v1 [cs.CV])

Objective: Lung cancer is the leading cause of cancer-related death worldwide. Computer-aided diagnosis (CAD) systems have shown significant promise in recent years for facilitating the effective detection and classification of abnormal lung nodules in computed tomography (CT) scans. While hand-engineered radiomic features have been traditionally used for lung cancer prediction, there have been significant recent successes achieving state-of-the-art results in the area of discovery radiomics. Here, radiomic sequencers comprising of highly discriminative radiomic features are discovered directly from archival medical data. However, the interpretation of predictions made using such radiomic sequencers remains a challenge. Method: A novel end-to-end interpretable discovery radiomics-driven lung cancer prediction pipeline has been designed, build, and tested. The radiomic sequencer being

Скрыть анонс
04:59 ScienceDaily.comGene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases

Researchers have successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, which affects more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.

Скрыть анонс
03:55 BBC HealthLiver transplant 'game changing' treatment approved

It's hoped perfusion machines that "warm livers" will increase the number of viable donated organs.

Скрыть анонс
01:18 ScienceDaily.comVaccine-preventable infections in pediatric transplant patients

Children who receive solid organ transplants are hospitalized due to vaccine-preventable infections at rates that are significantly higher than the general population.

Скрыть анонс
15.01.2019
19:30 CNN HealthStem cell therapy for relapsing MS proves effective and safe, study finds

An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research finds.

Скрыть анонс
19:09 Nanowerk.comEngineered T cells promote long-term organ transplant acceptance

Scientists discovered a molecular approach preventing rejection of the transplanted graft while simultaneously maintaining the ability to fight against infections.

Скрыть анонс
18:42 ScienceDaily.comEngineered T cells promote long-term organ transplant acceptance

Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers have now discovered a molecular approach preventing rejection of the transplanted graft while simultaneously maintaining the ability to fight against infections.

Скрыть анонс
17:18 InsideEVs.comBest And Worst Electric Cars For Regenerative Braking

Not all EV braking is created equal. When I drive an electric car for the first time, I’m always struck by how different it is from EVs that I previously experienced. More often than not, what separates them is not how they accelerate or handle – but how they brake. In the last couple of […]

Скрыть анонс
15:56 News-Medical.NetResearchers manipulate T cells to improve transplant success

Researchers have manipulated T cells in a way that prevents the rejection of transplanted organs, without affecting the immune system’s ability to fight microbial infection.

Скрыть анонс
15:47 Technology.orgDNA can help predicting if you will live longer or shorter than an average human

Everyone wants to live a long and healthy life. It is a bit of a goal that everyone

Скрыть анонс
14:16 BBC HealthRebecca Henderson: Transplant hope for rucksack heart woman

Scans show Rebecca Henderson has been clear of cancer for a year and is now eligible for a donor heart.

Скрыть анонс
06:06 Gizmag Massive Harvard-led genetic twin study homes in on the nature versus nurture debate


A massive new study is uncovering the effects of genes and environment in over 500 different conditions. Targeting over 50,000 twin pairs, the research is the first of its kind to use large-scale data analysis to evaluate the heritability of such a broad range of conditions.
.. Continue Reading Massive Harvard-led genetic twin study homes in on the nature versus nurture debate Category: Science Tags: Genetics Harvard

Скрыть анонс
01:47 Technology.orgGene-editing tool now being used to develop better antibiotics

A University of Wisconsin–Madison researcher and his collaborators at the University of California, San Francisco have repurposed the

Скрыть анонс
14.01.2019
22:29 Google news Sci/TechFresh Air: Transplant Surgeon Joshua Mezrich On 'When Death Becomes Life' : Shots - Health News - NPR

Fresh Air: Transplant Surgeon Joshua Mezrich On 'When Death Becomes Life' : Shots - Health News  NPR Joshua Mezrich has performed hundreds of kidney, liver and pancreas transplants. He shares stories from the operating room in his book, When Death ...

Скрыть анонс
21:22 News-Medical.NetMolecular hallmarks of tumor hypoxia across 19 cancer types discovered

Unlike healthy tissues, tumors thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, the impact of low oxygen, known as hypoxia, on tumor cells is poorly understood.

Скрыть анонс
18:57 BBC HealthLife-extending drug Perjeta approved for secondary breast cancer

The drug can prolong the lives of incurable breast cancer patients by up to 16 months.

Скрыть анонс
17:48 Nature.ComCRISPR adapted to respond to infected cells

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
17:30 Phys.orgStem cells regulate their fate by altering their stiffness

In adults, mesenchymal stems cells (MSCs) are primarily found in bone marrow and they play a vital role in repair of damaged organs. The transformation of a single MSC into complex tissue like cartilage and bone starts with its association with other MSCs in order to form microscopic clusters via a process termed as condensation. While it is known that this condensation step is important for skeletal development the exact role it plays in formation of bone and cartilage is not understood. A team led by Prof. Dr. Prasad Shastri and Dr. Melika Sarem of the Institute for Macromolecular Chemistry at the University of Freiburg present evidence for autonomous control of chondrogenesis in MSCs. These findings are published in the journal Stem Cell Research & Therapy.

Скрыть анонс
13:15 FT.com HealthWhat are the potential health benefits of gene editing?

Anjana Ahuja talks to a leading scientist from the Crick Institute about developments in gene editing

Скрыть анонс
13:15 FT.com ScienceWhat are the potential health benefits of gene editing?

Anjana Ahuja talks to a leading scientist from the Crick Institute about developments in gene editing

Скрыть анонс
11:32 BBC HealthRoyal Papworth Hospital marks heart transplant anniversary

The hospital's first such procedure was carried out on a 44-year-old patient on 14 January 1979.

Скрыть анонс
08:06 FT.com HealthNHS trials AI software to diagnose breast cancer

Kheiron’s test in England aimed at helping hospitals cope with shortage of radiologists

Скрыть анонс
08:06 FT.com ScienceNHS trials AI software to diagnose breast cancer

Kheiron’s test in England aimed at helping hospitals cope with shortage of radiologists

Скрыть анонс
07:34 FT.com HealthPodcast: What next for genome editing?

Anjana Ahuja talks to Professor Robin Lovell-Badge of the Crick Institute

Скрыть анонс
13.01.2019
20:51 FT.com HealthLife Biosciences joins the longevity race

US start-up looking at ways to extend life valued at $500m after funding round

Скрыть анонс
12.01.2019
13:32 Phys.orgGene-editing tool CRISPR repurposed to develop better antibiotics

A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.

Скрыть анонс
07:56 News-Medical.NetResearchers repurpose gene-editing tool CRISPR to develop better antibiotics

A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.

Скрыть анонс
07:33 News-Medical.NetNovel gene therapy could dampen drug-induced side effect in Parkinson's patients

A Michigan State University researcher has received a $2.8 million federal grant to develop a gene therapy that could reduce and possibly eliminate a frustrating side effect of a drug commonly prescribed to Parkinson's patients.

Скрыть анонс
04:16 ScienceDaily.comGene-editing tool CRISPR repurposed to develop better antibiotics

Scientists have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.

Скрыть анонс
11.01.2019
23:10 Reuters.com HealthLilly eyes more cancer deals, but wary of CAR-T, gene therapy

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.

Скрыть анонс
18:03 FierceBiotech.comAdding a 'switch' to Cas9 to make CRISPR gene editing safer

One challenge facing the development of CRISPR gene editing is the fear that the Cas9 "scissors" used in the technology could cause off-target effects. UC Berkeley researchers have come up with a “switch” mechanism that could keep the Cas9 enzyme turned off until it reaches its target site.

Скрыть анонс
16:34 News-Medical.NetCRISPR-Cas9 circular permutants can sense and respond to viral proteases

Using a technique called circular permutation, researchers at the University of California Berkeley have created a new suite of Cas9 variants called Cas9-CPs, which will simplify design of Cas9-fusion proteins for diverse applications beyond simple DNA cutting, such as base editing and epigenetic modifications.

Скрыть анонс
15:09 Technology.orgGiving Cas9 an ‘on’ switch for better control of CRISPR gene editing

CRISPR-Cas9 is a revolutionary tool in part because of its versatility: created by bacteria to chew up viruses,

Скрыть анонс
09:20 News-Medical.NetNew method modifies blood stem cells to reverse genetic mutation that causes IPEX

UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX.

Скрыть анонс
04:21 ScienceDaily.comCRISPR study reveals new immune system regulators

Scientists have created the first retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, which are key cells in the immune system. Researchers mapped the most important genes for controlling T helper cells, and identified several new regulatory genes. The results could help researchers develop new treatments to activate the immune system against tumours or infection.

Скрыть анонс
03:31 News-Medical.NetResearch suggests possible way to improve survival in African-Americans undergoing liver transplant

Among African-American adults undergoing liver transplant to treat liver cancer, patients whose organ donor was also African-American lived significantly longer than those with a racially unmatched donor, report authors of a new study using national data.

Скрыть анонс
00:43 ScienceDaily.comGiving Cas9 an 'on' switch for better control of CRISPR gene editing

Scientists have created an 'on' switch for CRISPR-Cas9 that allows it to be turned on in select cells only, specifically those that have a particular protein-cutting enzyme, or protease. Viruses produce such proteases, as do cancer cells, so the Cas9 variants -- called ProCas9 -- could be used as sensors for viral infections or cancer. The variants were discovered by circular permutations on wild-type Cas9 designed to produce a stripped-down Cas9 tuned to human cells.

Скрыть анонс
10.01.2019
20:55 TechnologyReview.comCongress is about to renew its ban on creating CRISPR babies in the US

Скрыть анонс
19:07 Phys.orgGiving Cas9 an 'on' switch for better control of CRISPR gene editing

CRISPR-Cas9 is a revolutionary tool in part because of its versatility: created by bacteria to chew up viruses, it works equally well in human cells to do all sorts of genetic tricks, including cutting and pasting DNA, making pinpoint mutations and activating or inactivating a gene.

Скрыть анонс
19:07 Phys.orgNew CRISPR-Cas9 variants can respond to viral proteases

Using a technique called circular permutation, researchers at the University of California Berkeley have created a new suite of Cas9 variants called Cas9-CPs, which will simplify design of Cas9-fusion proteins for diverse applications beyond simple DNA cutting, such as base editing and epigenetic modifications. The work appears January 10 in the journal Cell.

Скрыть анонс
16:50 ScienceDaily.comHRT tablets associated with increased risk of blood clots

Hormone replacement therapy (HRT) tablets are associated with a higher risk of rare but serious blood clots (known as venous thromboembolism or VTE), finds a large study.

Скрыть анонс
14:42 AzoRobotics.comArtificial Intelligence Used to Support Instant Diagnosis of Diabetic Eye Disease

Diabetic retinopathy is the main cause of vision loss in adults and its impact is growing around the world, with 191 million people estimated to be affected by 2030. There are no early-stage...

Скрыть анонс
14:30 BBC HealthQuadruple amputee given double hand transplant

Quadruple amputee Corinne Hutton, from Lochwinnoch in Renfrewshire, had been waiting five years for the surgery.

Скрыть анонс
10:53 Technology.orgStem cell study offers clues for optimizing bone marrow transplants and more

Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of

Скрыть анонс
03:11 BBC HealthSome HRT tablets 'linked to higher blood clot risk'

The overall risk remains low, with patches and gels the safest treatment, BMJ researchers say.

Скрыть анонс
02:39 News-Medical.NetResearch provides clues for understanding and optimizing bone marrow transplants

Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of cancers, blood disorders and immune diseases. Even though 22,000 of these procedures are performed each year in the US, much remains to be understood about how they work.

Скрыть анонс
01:45 ScienceDaily.comStem cell study offers clues for optimizing bone marrow transplants and more

A new study, conducted in mice, shows that successfully transplanted stem cells don't behave 'normally' as in a healthy person without a transplant. Instead, the radiation and high-dose chemotherapy used to wipe out diseased stem cells prior to transplantation appear to trigger 'extreme behavior' in the newly transplanted cells.

Скрыть анонс
01:39 TechInvestorNews.comThe doctor will see you now … on your phone, with an AI assistant: How tech is changing healthcare (Todd Bishop/GeekWire)

Todd Bishop / GeekWireThe doctor will see you now … on your phone, with an AI assistant: How tech is changing healthcare - What role will artificial intelligence play in healthcare? How can smartphones make healthcare more accessible? And whats the future of tech giants such as Amazon and Google in the world of health? Those are a few of the issues we discussed with a panel of health tech leaders during a ...

Скрыть анонс
09.01.2019
22:44 ScienceDaily.comFirst pregnancy after robot-assisted uterus transplant

Research on uterine transplantation is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.

Скрыть анонс
21:04 Nature.ComHigh levels of auxin signalling define the stem-cell organizer of the vascular cambium

Скрыть анонс
20:21 BBC HealthPM's pledge to baby Carter Cookson needing heart transplant

Carter Cookson has been given five weeks to live unless he receives a new heart.

Скрыть анонс
18:58 ScienceDaily.comCancer mortality milestone: 25 years of continuous decline

A steady, 25-year decline has resulted in a 27 percent drop in the overall cancer death rate in the United States, translating to approximately 2.6 million fewer cancer deaths between 1991 and 2016.

Скрыть анонс
18:24 NewScientist.ComStem cells implanted into the brain stop epilepsy seizures in rats

A radical approach of implanting stem cells into the brain could stop epilepsy seizures at their source, but the treatment has only been tested in rats so far

Скрыть анонс
18:24 NewScientist.ComBaby chicks could be given faecal transplants to ward off infections

Farmed chickens often carry diseases like Campylobacter, which can cause food poisoning, but faecal transplants dramatically slow the spread of the bacteria

Скрыть анонс
18:24 NewScientist.ComTop geneticist calls for global rules for ethical human genome editing

Following the shock announcement of the world's first genome-edited babies, geneticist Robin Lovell-Badge says the world must agree a set of safety protocols

Скрыть анонс
16:38 Google news HealthUS cancer death rate hits milestone: 25 years of decline - St George News

US cancer death rate hits milestone: 25 years of decline  St George NewsDoctors say lifestyle change could prevent half of Iowa's cancer cases  KCCI Des MoinesAs death rates from cancer decline, why are some communities faring worse?  PBS NewsHourAs cancer mortality declines, gap between rich and poor emerges  AxiosUS cancer death rate hits 25 years of decline, study says  CNNView full coverage on Google News

Скрыть анонс
16:38 Google news Sci/TechUS cancer death rate hits milestone: 25 years of decline - St George News

US cancer death rate hits milestone: 25 years of decline  St George NewsDoctors say lifestyle change could prevent half of Iowa's cancer cases  KCCI Des MoinesAs death rates from cancer decline, why are some communities faring worse?  PBS NewsHourAs cancer mortality declines, gap between rich and poor emerges  AxiosUS cancer death rate hits 25 years of decline, study says  CNNView full coverage on Google News

Скрыть анонс
15:52 MedicalNewsToday.comMedical News Today: 'Coaxing' stem cells to form new bone tissue

New research finds out how to drive stem cells to form new bone tissue, and these results could help improve outcomes for spinal surgeries.

Скрыть анонс
13:28 Google news Sci/TechWhoa, scientists want to use CRISPR to make one spicy tomato! - Fast Company

Whoa, scientists want to use CRISPR to make one spicy tomato!  Fast CompanyLet's Make Tomatoes Spicy With Genetic Engineering, Scientists Proclaim  GizmodoScientists say they could genetically engineer spicy tomatoes  BGRGenetically Engineered Spicy Tomatoes Could Be Created Soon  Radio.comReawakening chili genes could serve up spicy tomatoes  New AtlasView full coverage on Google News

Скрыть анонс
10:39 News-Medical.NetFirst woman pregnant after robot-assisted uterine transplantation

The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.

Скрыть анонс
09:58 Technology.orgNew CRISPR-based Technology Developed to Control Pests with Precision-guided Genetics

Combining historical lessons with modern genetic technologies, scientists at the University of California San Diego have developed a

Скрыть анонс
08:35 News-Medical.NetResearchers identify and overcome barrier in CRISPR gene editing to treat muscular dystrophy

The gene editing technique known as CRISPR is a revolutionary approach to treating inherited diseases. However, the tool has yet to be used to effectively treat long-term, chronic conditions.

Скрыть анонс
First← Previous12345678910Previous →Last